ReviewJournal of clinical tuberculosis and other mycobacterial diseases2026
Private sector engagement in tuberculosis detection: a bibliometric analysis.
Review in Journal of clinical tuberculosis and other mycobacterial diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents the first comprehensive bibliometric analysis of scientific publications in the field of the private sector's role in tuberculosis detection and diagnosis from 1964 to 2025. Using PRISMA, data were extracted from Scopus and Web of Science, yielding 616 original research articles published in 224 journals. Bibliometric performance analysis was done using Pivot Tables. Keyword co-occurrence analysis was performed using VOSviewer software to identify thematic structures. The results reveal a steady increase in publication activity since the early 2000s, reflecting growing recognition of the private sector as a critical actor in tuberculosis control. Analysis of the ten most cited articles revealed four recurring issues: suboptimal quality of care, diagnostic delays, high financial burdens on patients, and the critical need for structured public-private collaboration. The co-occurrence analysis identified five main thematic clusters. The largest cluster, "Delays and Catastrophic Costs," highlights persistent diagnostic delays, high costs, and fragmented care within the private sector. The clusters, "Diagnostic Challenges in Private Practice" and "Case Detection and Private Practitioners", further underscore deficiencies in diagnostic quality and coordination. Conversely, the clusters, "Public-Private Mix" and "Diagnostics and Private Providers", demonstrate the sector's potential to expand diagnostic coverage, enhance case notification, and reduce the burden on public facilities when effective collaboration and regulatory oversight exist. Despite encouraging progress being made, we identified gaps, particularly regarding regulatory mechanisms, cost-effectiveness evaluation, and data standardisation. Strengthening governance, integrating innovative diagnostics, and incentivising quality assurance are future research directions to fully harness the private sector's contribution to ending the tuberculosis epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.